NAPHTHYLCOMBRETASTATIN

ID: ALA85065

Max Phase: Preclinical

Molecular Formula: C21H20O3

Molecular Weight: 320.39

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): Naphtylcombretastatin
Synonyms from Alternative Forms(1):

    Canonical SMILES:  COc1cc(/C=C\c2ccc3ccccc3c2)cc(OC)c1OC

    Standard InChI:  InChI=1S/C21H20O3/c1-22-19-13-16(14-20(23-2)21(19)24-3)9-8-15-10-11-17-6-4-5-7-18(17)12-15/h4-14H,1-3H3/b9-8-

    Standard InChI Key:  GOOTUFTVCKSZRA-HJWRWDBZSA-N

    Associated Targets(Human)

    A549 127892 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    HT-29 80576 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    SK-MEL-28 48833 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    HCT-116 91556 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    HL-60 67320 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    HeLa 62764 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    HepG2 196354 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    HEK293 82097 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Associated Targets(non-human)

    P388 20296 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Tubulin beta chain 424 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Transcription factor SOX-18 84 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: NoOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 320.39Molecular Weight (Monoisotopic): 320.1412AlogP: 5.04#Rotatable Bonds: 5
    Polar Surface Area: 27.69Molecular Species: NEUTRALHBA: 3HBD: 0
    #RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
    CX Acidic pKa: CX Basic pKa: CX LogP: 4.83CX LogD: 4.83
    Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.62Np Likeness Score: 0.18

    References

    1. Maya AB, del Rey B, Lamamie de Clairac RP, Caballero E, Barasoain I, Andreu JM, Medarde M..  (2000)  Design, synthesis and cytotoxic activities of naphthyl analogues of combretastatin A-4.,  10  (22): [PMID:11086727] [10.1016/s0960-894x(00)00506-0]
    2. Pérez-Melero C, Maya AB, del Rey B, Peláez R, Caballero E, Medarde M..  (2004)  A new family of quinoline and quinoxaline analogues of combretastatins.,  14  (14): [PMID:15203159] [10.1016/j.bmcl.2004.04.098]
    3. Maya AB, Pérez-Melero C, Mateo C, Alonso D, Fernández JL, Gajate C, Mollinedo F, Peláez R, Caballero E, Medarde M..  (2005)  Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety.,  48  (2): [PMID:15658869] [10.1021/jm0310737]
    4. Alvarez C, Alvarez R, Corchete P, Pérez-Melero C, Peláez R, Medarde M..  (2007)  Synthesis and biological activity of naphthalene analogues of phenstatins: naphthylphenstatins.,  17  (12): [PMID:17434303] [10.1016/j.bmcl.2007.03.082]
    5. Mamidyala SK, Ramu S, Huang JX, Robertson AA, Cooper MA..  (2013)  Efficient synthesis of anacardic acid analogues and their antibacterial activities.,  23  (6): [PMID:23416004] [10.1016/j.bmcl.2013.01.074]
    6. Makar S, Saha T, Singh SK..  (2019)  Naphthalene, a versatile platform in medicinal chemistry: Sky-high perspective.,  161  [PMID:30366253] [10.1016/j.ejmech.2018.10.018]
    7.  (2018)  Inhibitors of sox18 protein activity for treating angiogenesis- and/or lymphangiogenesis-related diseases,